UPA Pigmentation Pathway Compound - Melanotan II (Vial Format)
Product Overview
UPA Melanotan II features a synthetic peptide compound commonly referenced in pigmentation and melanocortin pathway research contexts. This product is supplied in vial format and is intended for experienced customers familiar with compound handling and preparation.
Package Contents
1 × Melanotan II compound vial (10 mg / 10,000 mcg)
General Context
Melanotan II has been examined in research environments for its interaction with melanocortin receptors involved in pigmentation-related signalling pathways. These pathways are studied within broader frameworks of cellular communication, receptor activity, and appearance-adjacent research models.
Within scientific literature, Melanotan II is often grouped among compounds used to explore melanocyte signalling and pigment-related regulatory mechanisms.
Compound Information
Melanotan II compound
Supplied in vial format
Intended for controlled preparation and handling
Produced to established quality and handling standards
Format Information
Vial Format
This product is supplied in vial form and requires preparation prior to use. Intended for customers familiar with vial-based compound handling and appropriate preparation protocols.
Storage & Handling
Store according to packaging instructions
Protect from excessive heat and direct light
Do not use if the solution appears cloudy or contains visible particles
Intended Audience
This product is intended for experienced customers familiar with pigmentation-focused compounds and vial-format preparation.
No claims are made regarding tanning outcomes, skin colour changes, UV exposure, sun protection, appearance enhancement, or medical effects.
Disclaimer
This product is not intended to diagnose, treat, cure, or prevent any disease.
Additional Disclaimer
All compound products are supplied for informational and catalogue purposes only. Customers are responsible for ensuring appropriate handling, preparation, and compliance with applicable regulations.